Page 1

Your Catalyst to a Lucrative Business

Sevoflurane, Isoflurane and Desflurane Market Share, Size, Key Players, Research and Forecasts to 2022 | Hexa Research

“The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion by 2022 in comparison to USD 1.2 billion in 2014.�

Overview: The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion by 2022 in comparison to USD 1.2 billion in 2014. These three chemicals are inhalation agents and have been used by anesthesiologists, nurse anesthetists, and anesthesiology assistants on a consistent basis. They are very strong and cost less, with minimum damage to the ozone layer. Market Drivers One of the primary factors, triggering expansion in the sevoflurane, isoflurane and desflurane market includes cardiovascular and respiratory diseases affecting the geriatric population. Rising cancer, orthopedic, spinal and gastro-intestinal cases have also furthered the market. Cataract surgery is a major contributor to the global market and will need a higher production of these chemicals. Growing accidents and emergency cases also add income to the inhalation anesthesia market. Universal insurance coverage as well as constant improvements in medical infrastructure also ensure the development of the sevoflurane, isoflurane and desflurane market. These agents are administered to patients prior surgery, making the induction of general anesthesia much simpler.

Follow Us:


Your Catalyst to a Lucrative Business Browse Details of Report @ https://www.hexaresearch.com/research-report/sevoflurane-isofluranedesflurane-industry Products Overview Sevoflurane Sevoflurane is one of the most commonly used volatile anesthetic agents. It is administered to babies and children. Sevoflurane is ideal for patients with asthma or sensitive air passages. But its side-effects include delirium and agitation. It can be given quickly without the use of intravenous instruments. Isoflurane: Isoflurane is a halogen ether utilized frequently by veterinarians. It is administered intravenously, relaxes the muscles and reduces pain. Isoflurane has also been used for inducing sleepiness for long durations during surgery. It is expected to register a CAGR of about 10% by 2022.

Key Players: The market is currently dominated by AbbVie and Baxter International. However, it can expect strong competition from manufacturers like Lunan Pharmaceutical Group and Piramal Enterprises. Piramal Enterprises currently has isoflurane and sevoflurane production underway. It will manufacture generic desflurane by 2016. AbbVie has sevoflurane and isoflurane under production. Baxter International is the only one that manufactures all the three products. Anesthesia has some unhealthy effects. The recycling companies of Deltasorb Technologies and Anesthetic Gas Reclamation reprocess anesthesia containers and gases from hospital vents. Rising investments by the aforementioned players would also accelerate the sales of the sevoflurane, isoflurane and desflurane market. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/pharmaceuticalsindustry

Table of Content Executive Summary & Digital Transformation industry critical success factors Industry Outlook

Follow Us:


Your Catalyst to a Lucrative Business Industry Dynamics Digital Transformation Market drivers Digital Transformation Market restraints Digital Transformation Key Market Opportunities Digital Transformation Porters Analysis Digital Transformation - PESTEL Analysis Digital Transformation - Company Market Share Analysis Digital Transformation Application Outlook Digital Transformation Regional Outlook Digital Transformation Company profiles Research Methodology Research scope & assumptions List of data sources

About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their busines s environment and enable them to undertake strategic growth initiatives.

Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - https://www.hexaresearch.com

Follow Us:

Sevoflurane, Isoflurane and Desflurane Market Analysis Till 2022  

The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion by 2022 in comparison to USD 1.2 billion in 2014.

Sevoflurane, Isoflurane and Desflurane Market Analysis Till 2022  

The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion by 2022 in comparison to USD 1.2 billion in 2014.

Advertisement